Life sciences, the burgeoning asset class ready to emerge in Europe
As the sizeable transactions carried out in recent months by some of the world’s most prominent institutional players indicate, real estate investor interest for the life sciences sector is rising. Established, well-defined and specialised clusters have emerged in the US as a growing asset class. Still at a very early stage in Europe, it is poised to do the same on our continent.